Molecular Imaging: Page 32

Clarity hits milestone in study of radiopharmaceutical

By AuntMinnieEurope.com staff writers

Clarity Pharmaceuticals, the Australian-based radiopharmaceutical developer, has completed patient recruitment in the dosimetry phase of a study of its theranostic agent with copper-based radioisotopes for treating metastatic castration-resistant prostate cancer.

November 14, 2021

Goh provides glimpse into future world of hybrid imaging

By Frances Rylands-Monk

How can the clinical potential of PET/MRI be unlocked? What challenges lie ahead? Cancer imaging expert Prof. Vicky Goh took out her crystal ball and provided some insight into the future role of PET/MRI and how both modalities can be integrated effectively. She also touched on PET/CT.

November 8, 2021

EANM publishes guide on principles and practice of PET/CT

By AuntMinnieEurope.com staff writers

The European Association of Nuclear Medicine's Technologists Committee has published a free, practical 100-page guide outlining recent advancements in radioisotope imaging, with a special emphasis on PET/CT techniques.

November 4, 2021

Finnish group uses PET to assess brain changes in obesity

By AuntMinnieEurope.com staff writers

Changes in the brain, including an altered function of neural networks that regulate appetite and satiety, can be seen before people become obese, researchers from Finland have reported in a study involving PET.

November 3, 2021

Best Theratronics lands multiple cyclotron orders

By AuntMinnieEurope.com staff writers

TeamBest Global company Best Theratronics has garnered $30 million (26 million euros) worth of international orders for new cyclotron systems and upgrades.

October 25, 2021

German PET study sheds new light on long COVID

By Will Morton

Investigators from the University of Freiburg, Germany, have found that patients with long-term symptoms from COVID-19 are hampered by impaired cognitive functions, yet PET shows the cause appears to be unrelated to any pathological changes in the brain.

October 21, 2021

ITM secures supply deal with Clovis Oncology

By AuntMinnieEurope.com staff writers

German radiopharmaceutical firm ITM Isotope Technologies Munich has signed an agreement to supply its EndolucinBeta no-carrier-added lutetium-177 radiopharmaceutical precursor to Clovis Oncology.

October 18, 2021

German group uses PET tracer to pinpoint breast cancer

By Will Morton

Investigators from Muenster, Germany, have found an experimental radiotracer based on gallium-68 can help diagnose primary and metastatic tumors on PET/MRI scans in women with advanced breast cancer -- even those smaller than 1 cm.

October 17, 2021

Theragnostics enters licensing deal with AAA for Ga-68 PET

By AuntMinnieEurope.com staff writers

Theragnostics has signed a global licensing agreement with Advanced Accelerator Applications (AAA) to develop and commercialize gallium-68 (Ga-68) one-step PET radiopharmaceuticals.

September 26, 2021

Swiss group underlines potential benefits of second-look PET/CT

By Will Morton

Investigators from Bern in Switzerland think a second PET/CT scan is worthwhile before radiotherapy treatment, especially when delays of over four weeks occur after initial scans in patients with advanced head and neck squamous cell cancer.

September 14, 2021

Finnish team shines a light on why we crave food

By AuntMinnieEurope.com staff writers

PET imaging has revealed a connection in the brain between the opioid system and food craving triggered by external appetite stimuli, according to a recent study.

September 5, 2021

Eckert & Ziegler to amend file for GalliaPharm PET tracer

By AuntMinnieEurope.com staff writers

Eckert & Ziegler Radiopharma submitted an amendment to its drug master file to the U.S. Food and Drug Administration (FDA) for its GalliaPharm PET radiotracer.

September 2, 2021

Previous Page

Page 32 of 121

Next Page